Jennifer Helble

Jennifer Helble is a highly skilled scientist with extensive experience in immunology and biotechnology. Currently serving as a Senior Scientist at Crossbow Therapeutics, Inc., Jennifer has previously contributed as a Scientist II at Celsius Therapeutics, where multiple pre-clinical projects in inflammatory bowel disease (IBD) and oncology were advanced through designing co-culture assays and making key program decisions. Jennifer's academic background includes a Ph.D. in Immunology from Harvard University, where research focused on antigen-specific CD4+ T cell responses, and a B.A. in Biochemistry from Bowdoin College. Additional experience encompasses postdoctoral research at Tufts University, adjunct teaching at Emmanuel College, and various research assistant roles.